Richard J. Knox
Enact Pharma PLC
Porton Down Scientific Park
Salisbury
Wiltshire
UK
Name/email consistency: high
- CB 1954: from the Walker tumor to NQO2 and VDEPT. Knox, R.J., Burke, P.J., Chen, S., Kerr, D.J. Curr. Pharm. Des. (2003)
- Gene-directed enzyme prodrug therapy (GDEPT)--recognizing the present limitations of gene therapy for the treatment of cancer. Knox, R.J. Curr. Opin. Investig. Drugs (2001)